Lv21
176 积分 2023-04-18 加入
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
1个月前
已完结
Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
1个月前
已完结
TGF-β builds a dual immune barrier in colorectal cancer by impairing T cell recruitment and instructing immunosuppressive SPP1+ macrophages
1个月前
已完结
Prostate Cancer
1个月前
已完结
皖公网安备34019202002308
